Hey friends! We’re thrilled to share some exciting news from the world of IVF research. At our fertility center, we’re always eager to dive into studies that can enhance our techniques and protocols. Plus, participating in these studies often means that patients can enjoy some waived fees — like complimentary medications!
Study Criteria:
- Women aged 21-40 who are embarking on their first IVF journey with us
- Must have normal ovarian reserve testing (FSH levels < 10 mIU/mL and AMH > 1.0 ng/mL)
- No untreated hydrosalpinx
- No history of recurrent pregnancy loss
- No chromosomal translocations in either partner
- No genetic reasons for pre-implantation genetic diagnosis
What’s Provided:
- Up to 3000iu of stimulation medications (like Bravelle and/or Menopur)
- 2 boxes of Endometrin for your frozen embryo transfer cycle
Curious if this study is right for you? Chat with your physician or reach out to one of our offices!
In other news, if you’re looking for information about when to expect your little one, check out our other blog post on expected arrival dates. And if you’re considering home insemination, make sure to visit sites like Make a Mom for trusted tools and resources. Also, Hopkins Medicine offers fantastic insights into IVF and fertility services.
To sum it up, this new IVF study is a great opportunity for eligible women to receive valuable treatment options while contributing to fertility research. We’re excited to see the positive impact it can have on future families!